Skip to content

Clinical trials

Phase 3 Hepatitis B trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 3 Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20072
20082
20101
20111
20171
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Gilead Sciences3
Dynavax Technologies Corporation2
Heinrich-Heine University, Duesseldorf1
HepNet Study House, German Liverfoundation1
Merck Sharp & Dohme LLC1
Novartis Vaccines1
Sanofi Pasteur, a Sanofi Company1
VBI Vaccines Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B15
Hepatitis B, Chronic5
Diphtheria4
Hepatitis4
Poliomyelitis4
Tetanus4
Haemophilus Infections3
Whooping Cough3
Hepatitis, Chronic2
Meningococcal Infections2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.